Nucleotide receptors

Current Opinion in Neurobiology

Volumn 7, Issue 3, 1997, Pages 346-357

  North, R Alan ^a   Barnard, Eric A ^b  

^a GLAXOSMITHKLINE   (United States)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; CALCIUM ION; CATION CHANNEL; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHOLIPASE C; POTASSIUM CHANNEL; POTASSIUM ION; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; RECEPTOR SUBUNIT;

ION TRANSPORT; MACROPHAGE; MICROGLIA; PRIORITY JOURNAL; REVIEW; SENSORY NERVE CELL;

EID: 0030760262     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-4388(97)80062-1     Document Type: Article

References (107)

1. Burnstock G, Kennedy C. Is there a basis for distinguishing two types of P2 purinoceptor? Gen Pharmacol. 16:1985;433-440.
2. Kennedy C, Leff P. How should P2X receptors be classified pharmacologically? Trends Pharmacol Sci. 16:1995;168-174.
3. Bean BP. Pharmacology and electrophysiology of ATP-activated ion channels. Trends Pharmacol Sci. 13:1992;87-90.
4. Gordon JL. Extracellular ATP: effects, sources and fate. Biochem J. 233:1986;309-319.
5. 4 mRNA is abundantly expressed. of special interest.
6. Bo X, Zhang Y, Nassar M, Burnstock G, Schoepfer R. A P2X purinoceptor cDNA conferring a novel pharmacological profile. FEBS Lett. 375:1995;129-133.
7. Soto F, Garcia-Guzman M, Gomez-Hernandez JM, Hollmann M, Karschin C, Stühmer W. P2X4: an ATP-activated ionotropic receptor cloned from rat brain. Proc Natl Acad Sci USA. 93:1996;3684-3688.
8. Wang C, Namba N, Gonoi T, Inagaki N, Seino S. Cloning and pharmacological characterization of a fourth P2X receptor subtype widely expressed in brain and peripheral tissue. Biochem Biophys Res Commun. 220:1996;196-202 The findings of this study are relevant to the question of which purinoceptor underlies the responses of insulin-secreting cells to extracellular ATP. of special interest.
9. Seguela P, Haghihi A, Soghomonian J-J, Cooper E. A novel neuronal P2X ATP receptor ion channel with widespread distribution in the brain. J Neurosci. 16:1996;448-455.
10. 6. of special interest.
11. Garcia-Guzman M, Sotot F, Laube B, Stühmer W. Molecular cloning and functional expression of a novel rat heart P2X purinoceptor. FEBS Lett. 388:1996;123-127.
12. Soto F, Garcia-Guzman M, Karschin C, Stühmer W. Cloning and tissue distribution of a novel P2X receptor from rat brain. Biochem Biophys Res Commun. 223:1996;456-460.
13. 7 receptor cDNA was isolated from rat brain, but the properties of the expressed receptor correspond closely to those previously attributed to the P2Z receptor of macrophages (cf. [4]). of special interest.
14. Valera S, Talabot F, Evans RJ, Gos A, Antonarakis SE, Morris MA, Buell GN. Characterization and chromosomal localization of a human P2X receptor from urinary bladder. Recept Channels. 3:1995;283-289.
15. 3 receptors had hitherto been thought to be restricted to a subset of sensory neurons; this paper shows that the RNA is also abundant in heart (from which the human cDNA was isolated) and found in the spinal cord. in press.
16. 2+ (8%) for a heterologously expressed P2X receptor. of special interest.
17. 7): cloning and expression of a human cDNA. J Biol Chem. 272:1997;5482-5486 ATP and its 2′,3′-(benzoyl-4-benzoyl) analogue are less effective at permeabilizing cells expressing the human P2X7 receptor than cells expressing the rat P2X7 receptor. Expression of rat/human chimeras indicates that the difference results, in part, from differences in the long carboxy-terminal tail of the protein. of special interest.
18. 6. of special interest.
19. Brake AJ, Wagenbach MJ, Julius D. New structural motif for ligand-gated ion channels defined by ionotropic ATP receptor. Nature. 371:1994;519-523.
20. 2 receptor. Mol Pharmacol. 1997;. in press.
21. Housley GD, Greenwood D, Bennett T, Ryan AF. Identification of a short form of the P2XR1-purinoceptor subunit produced by alternative splicing in the pituitary and choclea. Biochem Biophys Res Commun. 212:1995;501-508.
22. Werner P, Seward EP, Buell GN, North RA. Domains of P2X receptors involved in desensitization. Proc Natl Acad Sci USA. 93:1996;15485-15490.
23. Buell G, Michel AD, Lewis C, Collo G, Humphrey PPA, Surprenant A. P2X1 receptor activation in HL60 cells. Blood. 87:1996;2659-2664.
24. MacKenzie AB, Mahaut-Smith MP, Sage SO. Activation of receptor-operated cation channels via P2X not P2T purinoceptors in human platelets. J Biol Chem. 271:1996;2879-2881.
25. + channels, the other major class of membrane channels with two transmembrane domains and a large extracellular loop in each subunit. of special interest.
26. 33P]ATP. Br J Pharmacol. 117:1996;1254-1260.
27. Michel AD, Lundstrom K, Buell GN, Surprenant A, Valera S, Humphrey PPA. A comparison of the binding characteristics of recombinant P2X1 and P2X2 purinoceptors. Br J Pharmacol. 118:1996;1806-1813.
28. 4 receptors and that their action is allosteric. of special interest.
29. 2 receptor contribute to the lining of the ionic pore. of special interest.
30. Vulchanova L, Arvidsson U, Riedl M, Wang J, Buell G, Surprenant A, North RA, Elde RP. Differential distribution of two ATP-gated ion channels (P2X receptors) determined by immunocytochemistry. Proc Natl Acad Sci USA. 93:1996;8063-8067.
31. 3 subunits. of special interest.
32. 3 receptor subunits in monkey and rat sensory neurons and their central terminals. Neuropharmacology. 1997;. in press.
33. Illes P, Nieber K, Nörenberg W. Electrophysiological effects of ATP on brain neurons. J Auton Pharmacol. 1997;. in press.
34. Balachandran C, Bennett MR. ATP-activated cationic and anionic conductances in cultured rat hippocampal neurons. Neurosci Lett. 204:1996;73-76.
35. Hiruma H, Bourque CW. P2 purinoceptor-mediated depolarization of rat supraoptic neurosecretory cells in vitro. J Physiol. 489:1995;805-811.
36. Fröhlich R, Boehm S, Illes P. Pharmacological characterization of P2 purinoceptor types in rat locus coeruleus neurons. Eur J Pharmacol. 315:1996;255-261.
37. Chessell IP, Michel AD, Humphrey PPA. Functional evidence for multiple purinoceptor subtypes in the rat medial vestibular nucleus. Neuroscience. 77:1997;783-791.
38. Khakh BS, Humphrey PPA, Henderson G. ATP-gated cation channels (P2X purinoceptors) in trigeminal mesencephalic nucleus neurones of the rat. J Physiol. 498:1997;709-715.
39. 2+ in rat nodose ganglion neurons. J Neurophysiol. 76:1996;3048-3058.
40. Li C, Peoples RW, Weight FF. Enhancement of ATP-activated current by protons in dorsal root ganglion neurons. Pflugers Arch. 433:1997;446-454.
41. 2x purinoceptor in cultured neurones of the rat dorsal root ganglia. Br J Pharmacol. 118:1996;951-956.
42. 2x3 receptor subunits can account for ATP-gated currents in sensory neurones. Nature. 377:1995;432-434.
43. Von Kügelgen I, Norenberg W, Illes P, Schobert A, Starke K. Differences in the mode of stimulation of cultured rat sympathetic neurons between ATP and UDP. Neuroscience. 78:1997;935-941.
44. Giniatullin R, Khiroug L, Talantova M, Nistri A. Fading and rebound of currents induced by ATP in PC12 cells. Br J Pharmacol. 119:1996;1045-1053.
45. Nishimura T, Tokimasa T. Purinergic cation channels in neurons of rabbit vesicle parasympathetic ganglia. Neurosci Lett. 212:1996;215-217.
46. 2X-receptors of myenteric neurons from the guinea-pig ileum and their unusual pharmacological properties. Br J Pharmacol. 119:1996;1541-1548.
47. Zhou X, Galligan JJ. P2X purinoceptors in cultured myenteric neurons of guinea pig small intestine. J Physiol. 496:1996;719-729 A proportion of guinea pig myenteric neurons have synaptic potentials medicated by ATP acting at P2X receptors. This paper indicates that the myenteric neurons, like dorsal root ganglion cells (see [41] and references therein to earlier work) express two types of P2X receptor: one is activated by both ATP and αβmeATP and undergoes rapid desensitization, whereas the other is not activated by αβmeATP and shows little desensitization. of special interest.
48. 7 receptors, but ATP does not permeabilize the cells. of special interest.
49. Raybould NP, Housley GD. Variation in expression of the outer hair cell P2X receptor conductance along the guinea-pig cochlea. J Physiol. 498:1997;717-727.
50. Van Den Abbeele T, Tran Ba Hu P, Teulon J. Modulation by purines of calcium-activated non-selective cation channels in the outer hair cells of the guinea pig cochlea. J Physiol. 494:1996;77-80.
51. Sugasawa M, Erostegui C, Blanchet C, Dulon D. ATP activates non-selective cation channels and calcium release in inner hair cells of the guinea-pig cochlea. J Physiol. 491:1996;707-718.
52. Sun XP, Stanley EF. An ATP-activated, ligand-gated ion channel on a cholinergic presynaptic nerve terminal. Proc Natl Acad Sci USA. 93:1996;1859-1863.
53. Silinsky EM, Redman RS. Synchronous release of ATP and neurotransmitter within milliseconds of a motor nerve impulse in the frog. J Physiol. 492:1996;815-822.
54. Buller KM, Khanna S, Sibbald JR, Day TA. Central noradrenergic neurons signal via ATP to elicit vasopressin responses to haemorrhage. Neuroscience. 73:1996;637-642 One of the few suggestions that synaptic transmission mediated by ATP is involved in reflex activity of the nervous system. See also [106]. of special interest.
55. 2-purinoceptor antagonists. J Auton Pharmacol. 1997;. in press.
56. Edwards FA, Gibb AJ, Colquhoun D. ATP receptor-mediated synaptic currents in the central nervous system. Nature. 359:1992;144-147.
57. Di Virgilio F. The P2Z purinoceptor, an intriguing role in immunity, inflammation and cell death. Immunol Today. 16:1995;524-528.
58. 7 receptor. Neuropharmacology. 1997;. in press.
59. Haas S, Brockhaus J, Verkhratsky A, Kettenmann H. ATP-induced membrane currents in ameboid microglia acutely isolated from mouse brain slices. Neuroscience. 75:1996;257-261.
60. Ferrari D, Villalba M, Chiozzi P, Falzoni S, Ricciardi-Castagnoli P, Di Virgilio F. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J Immunol. 156:1996;1531-1539.
61. Di Virgilio F, Ferrari D, Chiozzi P, Falzoni S, Sanz JM, dal Susino M, Mutini C, Nhanau S, Baricordi OR. Purinoceptor function in the immune system. Drug Dev Res. 39:1996;319-329.
62. Webb TE, Simon J, Krishek BJ, Bateson AN, Smart TG, King BF, Burnstock G, Barnard EA. Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett. 324:1993;219-225.
63. Simon J, Webb TE, King BF, Burnstock G, Barnard EA. Characterization of a recombinant P2Y purinoceptor. Eur J Pharmacol. 291:1995;281-289.
64. Simon J, Webb TE, Barnard EA. Characterization of a P2Y purinoceptor in the brain. Pharmacol Toxicol. 76:1995;302-307.
65. Filtz TM, Li Q, Boyer JL, Nicholas RA, Harden TK. Expression of a cloned P2Y purinergic receptor that couples to phospholipase C. Mol Pharmacol. 46:1994;8-14.
66. Tokuyama Y, Hara M, Jones EMC, Fan Z, Bell GI. Cloning of rat and mouse P2Y purinoceptors. Biochem Biophys Res Commun. 211:1995;211-218.
67. Henderson DJ, Elliot DG, Smith GM, Webb TE, Dainty IA. Cloning and characterization of a bovine P2Y receptor. Biochem Biophys Res Commun. 212:1995;648-656.
68. 1 purinoceptor. Biochem Biophys Res Commun. 218:1996;783-788.
69. Léon C, Vial C, Cazenave J-P, Cachet C. Cloning and sequencing of a human cDNA encoding endothelial P2Y1 purinoceptor. Gene. 171:1996;295-297.
70. Schachter JB, Li Q, Boyer JL, Nicholas RA, Harden TK. Second messenger cascade specificity and pharmacological selectivity of the human P2Y1 purinoceptor receptor. Br J Pharmacol. 118:1996;167-173.
71. 35S]dATPαS binding sites in the adult rat neuraxis. Neuropharmacology. 1997;. in press.
72. Lustig KD, Shiau AK, Brake AJ, Julius D. Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc Natl Acad Sci USA. 90:1993;5113-5117.
73. Parr CE, Sullivan DM, Paradiso AM, Lazarowski ER, Burch IH, Olsen JC, Erb L, Weisman GA, Boucher RC, Turner JT. Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc Natl Acad Sci USA. 91:1994;3275-3279.
74. Chen Z-P, Krull N, Xu S, Levy A, Lightman SL. Molecular cloning and functional characterization of a rat pituitary G protein-coupled adenosine triphosphate (ATP) receptor. Endocrinology. 137:1996;1833-1840.
75. 2Y-purinoceptor agonists that are derivatives of adenosine 5′-monophosphate. Br J Pharmacol. 118:1996;1959-1964.
76. 6. of special interest.
77. 3) activated preferentially by nucleoside diphosphates. Mol Pharmacol. 50:1996;258-265.
78. Communi D, Pirotton S, Parmentier M, Boeynaems J-M. Cloning and functional expression of a human uridine nucleotide receptor. J Biol Chem. 270:1995;30849-30852 See annotation [79]. of special interest.
79. 4) at which uridine nucleotides are highly active and ATP is of only low potency (i.e. a pyrimidinoceptor); such a receptor had been hypothesized to exist, based on tissue responses, by several authors earlier. of special interest.
80. 4 receptors - characterization of a suramin and PPADS-insensitive response to UTP. Br J Pharmacol. 119:1996;1301-1303.
81. Ralevic V, Burnstock G. Discrimination by PPADS between endothelial P2Y- and P2U-purinoceptors in the rat isolated mesenteric arterial bed. Br J Pharmacol. 118:1996;428-434.
82. 5. Biochem Biophys Res Commun. 219:1996;105-110.
83. Kaplan MH, Smith DI, Sundick RS. Identification of a G protein coupled receptor induced in activated T cells. J Immunol. 151:1993;628-636.
84. 2). This is deduced to be an immediate early gene response, providing feedback signalling from extracellular ATP. of special interest.
85. 2 nucleotide receptor. J Biol Chem. 270:1995;26152-26158.
86. 6 receptor. Biochem Biophys Res Commun. 222:1996;303-308.
87. 2+ transients. It was used here to clone the cDNA for a P2Y-related sequence (see Note added in proof). of special interest.
88. Bogdanov YD, Dale L, King BF, Whittock N, Bumstock G. Early expression of a novel nucleotide receptor in the neural plate of Xenopus embryos. J Biol Chem. 272:1997;12583-12590.
89. Barnard EA, Webb TE, Simon J, Kunapuli SP. The diverse series of recombinant P2Y purinoceptors. Ciba Found Symp. 198:1996;166-180.
90. 2). Mutagenesis to remove the positive charge at several sidechains in TM6 and TM7 markedly decreased nucleotide potencies. of special interest.
91. Van Rhee AM, Fischer B, Van Galen PJM, Jacobson KA. Modelling the P2Y purinoceptor using rhodopsin as template. Drug Des Discov. 13:1995;133-154.
92. Van Rhee AM, Jacobson KA. Molecular architecture of G protein-coupled receptors. Drug Dev Res. 37:1996;1-38 A comprehensive listing of the effects of all mutation and domain exchanges reported for the seven-transmembrane receptors (in general). A large number of positions can affect small-ligand agonist or antagonist activity, especially in TM3, TM5, TM6 and TM7. Direct versus indirect effects of the mutations have in most cases not been distinguishable. of special interest.
93. 2Y purinergic receptors in a rat brain microvascular endothelial cells. Br J Pharmacol. 115:1995;1199-1203.
94. 1 receptors, determined by their intracellular environment. of special interest.
95. 1 and 'P2T' receptors are probably identical. of special interest.
96. 2 purinoceptor-operated potassium channel in rat cerebellar neurons. Biochem Biophys Res Commun. 218:1996;67-71.
97. + channels that can be opened through muscarinic receptors (see also [96]). of special interest.
98. North RA. Drug receptors and the inhibition of nerve cells. Br J Pharmacol. 98:1989;13-28.
99. Filippov AK, Brown DA. Activation of nucleotide receptors inhibits high-threshold calcium currents in NG108-15 neuronal hybrid cells. Eur J Neurosci. 8:1996;1149-1155.
100. 2 alone, with patch-clamp recording. of special interest.
101. 2+ channel currents in cultured bovine adrenal chromaffin cells. Neuron. 16:1996;1027-1036.
102. 1 purinergic receptors in sensory neurons: contributions to touch-induced impulse generation. Proc Natl Acad Sci USA. 93:1996;10465-10470.
103. Schlosser SF, Burgstahler AD, Nathanson MH. Isolated rat hepatocytes can signal to other hepatocytes and bile duct cells by release of nucleotides. Proc Natl Acad Sci USA. 93:1996;9948-9953.
104. Wang Y, Roman R, Lidofsky SD, Fitz JG. Autocrine signaling through ATP release represents a novel mechanism for cell volume regulation. Proc Natl Acad Sci USA. 93:1996;12020-12025.
105. Dale HH, Feldberg W, Vogt M. Release of acetylcholine at voluntary nerve endings. J Physiol. 86:1936;353-380.
106. Dale N, Gilday D. Regulation of rhythmic movements by purinergic neurotransmitters in frog embryos. Nature. 383:1996;259-262.
107. 4 that mediates chemotaxis. Nature. 387:1997;620-624.